Light Mode
$1.23 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.23, $0.03 below the day’s high of $1.26
+0.60 (+93.69%) / 6M
Momentum, market sentiment, and recent alerts
MTNB reads not so good: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +6.0%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.